Citation tools
"CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window." Journal of Pharmacology and Experimental Therapeutics
352.3
(2015):
568-578.
Web. 19 April. 2024.